Echo Therapeutics (ECTE) Posts Wider than Expected Q1 Loss of 8c/Share

Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $30.93 thousand versus the consensus estimate of $80 thousand.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Cisco rating cut at HSBC as analyst sees a lack of catalysts